Loading…
OnKure Therapeutics, Inc. is projected to rise to $4.16 by 2027, a +9% move from its current price of $3.82. OKUR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $3.73 | $3.82 | $3.91 | +0.01% |
| Aug 5 | $3.69 | $3.82 | $3.96 | +0.01% |
| Aug 6 | $3.66 | $3.82 | $3.99 | +0.02% |
| Aug 7 | $3.64 | $3.82 | $4.01 | +0.03% |
| Aug 8 | $3.62 | $3.82 | $4.04 | +0.04% |
| Aug 9 | $3.60 | $3.82 | $4.06 | +0.04% |
| Aug 10 | $3.58 | $3.82 | $4.08 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.58 | $3.82 | $4.08 | +0.05% |
| Week 2 | $3.49 | $3.82 | $4.19 | +0.10% |
| Week 3 | $3.42 | $3.83 | $4.28 | +0.15% |
| Week 4 | $3.36 | $3.83 | $4.36 | +0.20% |
| Week 5 | $3.31 | $3.83 | $4.43 | +0.25% |
| Week 6 | $3.27 | $3.83 | $4.49 | +0.30% |
| Week 7 | $3.23 | $3.83 | $4.55 | +0.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate is OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation, in Phase 1 clinical trials for solid tumors including breast cancer.
The company was founded in 2011 and is headquartered in Boulder, Colorado.
OKUR is the stock ticker for OnKure Therapeutics, Inc. It currently trades at $4.10 per share, has a market capitalization of $165.62M, and is ranked 3856.
A major floor 19.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 20.4% above — a clean break opens room to run.
A major ceiling 38.0% above — clearing it would confirm fresh momentum.
Key OKUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OKUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.95 | Sell | $3.96 | Sell |
| MA 10 | $4.07 | Sell | $4.04 | Sell |
| MA 20 | $4.19 | Sell | $4.13 | Sell |
| MA 50 | $4.23 | Sell | $4.18 | Sell |
| MA 100 | $4.22 | Sell | $4.03 | Sell |
| MA 200 | $3.56 | Buy | $4.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.47 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -164.65 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -9.26 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.17 | Sell |
| Awesome (5,34) | -0.31 | Sell |
| Ultimate (7,14,28) | 21.28 | Buy |
| Momentum (10) | -0.38 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 3.86 | Sell |
| ADX (14) | 13.15 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40, indicating neutral momentum, and the 50-day simple moving average is $4.12, versus the 200-day SMA of $3.50.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.32 | $3.82 | $4.72 | 0% | Neutral | |
| $3.35 | $4.16 | $5.44 | +9% | Neutral | |
| $3.63 | $4.62 | $6.25 | +21% | Bullish | |
| $3.98 | $5.17 | $7.19 | +35% | Bullish | |
| $4.54 | $6.01 | $8.54 | +57% | Bullish | |
| $4.42 | $5.95 | $8.63 | +56% | Bullish | |
| $4.21 | $5.75 | $8.48 | +50% | Bullish | |
| $4.57 | $6.33 | $9.49 | +66% | Bullish | |
| $4.84 | $6.80 | $10.34 | +78% | Bullish | |
| $5.59 | $7.96 | $12.28 | +108% | Bullish | |
| $6.35 | $9.58 | $15.65 | +151% | Bullish | |
| $11.08 | $18.46 | $32.78 | +383% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.32 | $3.82 | $4.42 | +0.00% |
| September 2026 | $3.15 | $3.72 | $4.50 | -2.70% |
| October 2026 | $3.24 | $3.84 | $4.70 | +3.44% |
| November 2026 | $3.22 | $3.84 | $4.73 | -0.14% |
| December 2026 | $3.18 | $3.81 | $4.72 | -0.89% |
Click any year to see its month-by-month OKUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OKUR is projected to trade between $2.32 and $4.72, averaging $3.82 — a potential gain of 0% from today's $3.82. Price action looks broadly range-bound.
OnKure Therapeutics, Inc.'s 2027 outlook centres on $4.16, within a $3.35 to $5.44 range. That is up +9% on the projected 2026 average. That marks a +9% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, OKUR could reach as high as $6.25, with a base case around $4.62 and support toward $3.63 — roughly +21% from $3.82. Momentum favours further upside here.
Expect OKUR to range from $3.98 to $7.19 through 2029. The $5.17 average target implies a +35% move from current prices. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The OKUR price prediction for 2030 points to an average of $6.01 (low $4.54, high $8.54) — a potential gain of +57% on today's $3.82. Momentum favours further upside here.
In 2031, OKUR is projected to trade between $4.42 and $8.63, averaging $5.95 — a potential gain of +56% from today's $3.82. That is -1% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
OnKure Therapeutics, Inc.'s 2032 outlook centres on $5.75, within a $4.21 to $8.48 range. That is -3% versus the projected 2031 average. That marks a +50% change versus current levels. Momentum favours further upside here.
By 2033, OKUR could reach as high as $9.49, with a base case around $6.33 and support toward $4.57 — roughly +66% from $3.82. Buyers look set to stay in control over this stretch.
Expect OKUR to range from $4.84 to $10.34 through 2034. The $6.80 average target implies a +78% move from current prices. That is up +7% on the projected 2033 average. Momentum favours further upside here.
The OKUR price prediction for 2035 points to an average of $7.96 (low $5.59, high $12.28) — a potential gain of +108% on today's $3.82. Buyers look set to stay in control over this stretch.
In 2040, OKUR is projected to trade between $6.35 and $15.65, averaging $9.58 — a potential gain of +151% from today's $3.82. That is up +20% on the projected 2035 average. Momentum favours further upside here.
OnKure Therapeutics, Inc.'s 2050 outlook centres on $18.46, within a $11.08 to $32.78 range. That is up +93% on the projected 2040 average. That marks a +383% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in OKUR today (≈ 261.780105 OKUR) could be worth
$4,831.6
+$3,831.6 (+383%) by 2050 · US Dollar
Based on the average projected OKUR price of $18.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OKURwould be worth at today's price.
$1,000 invested in OKUR on Jul 31, 2025 (≈ 452.48868 OKUR) would be worth
$1,728.51
+$728.51 (+72.9%) today · 1.73× · US Dollar
Based on a OKUR entry price of $2.21 vs. today's $3.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.12 | $927.18 | -7.3% |
| 1 month ago | $4.46 | $856.5 | -14.3% |
| 3 months ago | $4.73 | $807.61 | -19.2% |
| 6 months ago | $2.64 | $1,446.97 | +44.7% |
| 1 year ago | $2.21 | $1,728.51 | +72.9% |
| All time (5.0y) ago | $81.4 | $46.93 | -95.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OKUR forecast.
Our base-case forecast reaches $7.60 around 2035.
Implied market cap at $7.60: $307.01M
The multi-year forecast shows a bullish trajectory with rising averages over time. In 2027 the average price is $4.83, in 2028 it is $5.71, and by 2030 the average reaches $7.85 with a ROI of 91.6%. The outlook extends to 2040 with an average of $14.74 and a ROI of 259.5%, and to 2050 with an average of $30.24 and a ROI of 637.6%.
The sentiment is BULLISH from 2028 onward, supported by projected price advances to higher maxima in later years.
Tap a question to reveal the answer.
Avg $7.85; min $5.80; max $11.47; ROI 91.6%; sentiment BULLISH.
Forecasts show a path from 2026 avg $4.10 toward higher averages by 2050, with a bullish sentiment and ROI up to 637.6% by 2050.
Yes. The forecast shows 2032 max $11.67 and 2033 max $13.77, with higher maxima in later years (e.g., 2034 max $15.44, 2035 max $18.86, 2040 max $25.07, 2050 max $56.35).
Current price is $4.10 and market cap is $165.62M.
Sentiment NEUTRAL; RSI 14 is 40; SMA50 is $4.12; SMA200 is $3.50; support is $4.10; resistance is $4.60; 30-day range is $3.41 to $4.93.
OnKure Therapeutics, Inc. Community Discussion
0Share your OnKure Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.